Searched for
DENGUE VACCINE PRODUCTION
India moves closer to dengue vaccine as final trials underwayAn Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...- Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...
- Dengue virus fever in USA: Over 9.7 million cases reported. Check symptoms, treatmentDengue fever is reported in the US as CDC has provided details about the Symptoms and treatment.
- SII, the world’s largest vaccine maker, sees demand doubling in five yearsSerum Institute of India Pvt. is gearing up to meet the growing demand for life-saving vaccines, with expectations to double sales in the n...
- Japan's Takeda in regulatory talks to launch dengue vaccine in IndiaThe Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...
- Study suggests prior Zika infection may heighten risk of severe dengueA recent study suggests that individuals previously infected with Zika may face an increased risk of developing severe dengue and requiring...
- Countries which chose Covishield fared better than those that took mRNA vax: Adar PoonawallaCovovax, which is our Novavax product, is proven to be the best against Omicron and Omicron sub variants. It is also the only vaccine from ...
- Sanofi bets on India with portfolio of drugs for diabetes, rare diseasesSanofi reported one of the sharpest falls in its global sales in the fourth quarter, owing to the decline in diabetes drug sales, a controv...
- Sun Pharma, NIV join hands to fight zika, chikungunya, dengueUnder the agreement, Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems, the c...
- Why India is struggling to introduce dengue vaccinesThe ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.
- Developing vaccine for Zika to take time: Johnson & Johnson's Paul StoffelsThe Zika virus, which was declared a global threat by the World Health Organisation last week, has been rapidly spreading in South America ...
- Bharat Biotech likely to be valued at $600 million as top PE firms queue up to buy stakeDomestic private equity fund ICICI Venture, International Finance Corp, the investment arm of World Bank, will exit their almost 10-yr inve...
- India waives large-scale clinical trials for Sanofi's dengue vaccineAn expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine develope...
- Sanofi gets Philippines' approval to market dengue vaccineSanofi Pasteur said Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for ...
- Government may exempt Sanofi’s dengue vaccine from large-scale clinical trialsIf cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...
- Sanofi bets on dengue vaccine, 5 other drugs to bolster India playFrench co plans to bring raft of innovative products, including preventive dengue vaccine; move may improve company’s prospects over its ri...
- First drug treatment for dengue in the offingDengue virus is estimated to infect up to 400 million people globally each year, researchers said.
- Powerful antibody against dengue virus foundWhile antibody 5J7 has been found to be effective against DENV-3, the remaining two serotypes of dengue virus (DENV-2 and DENV-4) have to b...
- Innovation key to ride vaccine boom: Dr Rajesh Jain, Panacea BiotecIt is a capital-intensive business where companies require upfront payments to fund R&D activities, says Dr Rajesh Jain, joint managing dir...
- Sanofi arm may make India global output hub for vaccinesIndia may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.
Load More
